106 related articles for article (PubMed ID: 11956084)
1. Absence of the CD44 gene prevents sarcoma metastasis.
Weber GF; Bronson RT; Ilagan J; Cantor H; Schmits R; Mak TW
Cancer Res; 2002 Apr; 62(8):2281-6. PubMed ID: 11956084
[TBL] [Abstract][Full Text] [Related]
2. Deletion of the WNT target and cancer stem cell marker CD44 in Apc(Min/+) mice attenuates intestinal tumorigenesis.
Zeilstra J; Joosten SP; Dokter M; Verwiel E; Spaargaren M; Pals ST
Cancer Res; 2008 May; 68(10):3655-61. PubMed ID: 18483247
[TBL] [Abstract][Full Text] [Related]
3. Cluster of differentiation 44 promotes osteosarcoma progression in mice lacking the tumor suppressor Merlin.
Ma J; Klemm J; Gerardo-Ramírez M; Frappart L; Castven D; Becker D; Zoch A; Parent R; Bartosch B; Minnich K; Giovannini M; Danckwardt S; Hartmann N; Morrison H; Herrlich P; Marquardt JU; Hartmann M
Int J Cancer; 2020 Nov; 147(9):2564-2577. PubMed ID: 32525563
[TBL] [Abstract][Full Text] [Related]
4. Osterix, a transcription factor for osteoblast differentiation, mediates antitumor activity in murine osteosarcoma.
Cao Y; Zhou Z; de Crombrugghe B; Nakashima K; Guan H; Duan X; Jia SF; Kleinerman ES
Cancer Res; 2005 Feb; 65(4):1124-8. PubMed ID: 15734992
[TBL] [Abstract][Full Text] [Related]
5. CD44 variant isoforms promote metastasis formation by a tumor cell-matrix cross-talk that supports adhesion and apoptosis resistance.
Klingbeil P; Marhaba R; Jung T; Kirmse R; Ludwig T; Zöller M
Mol Cancer Res; 2009 Feb; 7(2):168-79. PubMed ID: 19208744
[TBL] [Abstract][Full Text] [Related]
6. Integrative genome analysis of somatic p53 mutant osteosarcomas identifies Ets2-dependent regulation of small nucleolar RNAs by mutant p53 protein.
Pourebrahim R; Zhang Y; Liu B; Gao R; Xiong S; Lin PP; McArthur MJ; Ostrowski MC; Lozano G
Genes Dev; 2017 Sep; 31(18):1847-1857. PubMed ID: 29021240
[No Abstract] [Full Text] [Related]
7. A caspase-6 and anti-HER2 antibody chimeric tumor-targeted proapoptotic molecule decreased metastasis of human osteosarcoma.
Wang LF; Zhou Y; Xu YM; Qiu XC; Zhou BG; Wang F; Long H; Chen X; Yang TT; Ma BA; Fan QY; Yang AG
Cancer Invest; 2009 Aug; 27(7):774-80. PubMed ID: 19488908
[TBL] [Abstract][Full Text] [Related]
8. Genetic deletion of receptor for hyaluronan-mediated motility (Rhamm) attenuates the formation of aggressive fibromatosis (desmoid tumor).
Tolg C; Poon R; Fodde R; Turley EA; Alman BA
Oncogene; 2003 Oct; 22(44):6873-82. PubMed ID: 14534534
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous and irradiation-induced tumor susceptibility in BRCA2 germline mutant mice and cooperative effects with a p53 germline mutation.
McAllister KA; Houle CD; Malphurs J; Ward T; Collins NK; Gersch W; Wharey L; Seely JC; Betz L; Bennett LM; Wiseman RW; Davis BJ
Toxicol Pathol; 2006; 34(2):187-98. PubMed ID: 16546942
[TBL] [Abstract][Full Text] [Related]
10. p53 gene gets altered by various mechanisms: studies in childhood sarcomas and retinoblastoma.
Ghule P; Kadam PA; Jambhekar N; Bamne M; Pai S; Nair C; Banavali S; Puri A; Agarwal M
Med Sci Monit; 2006 Dec; 12(12):BR385-396. PubMed ID: 17136003
[TBL] [Abstract][Full Text] [Related]
11. Fas-negative osteosarcoma tumor cells are selected during metastasis to the lungs: the role of the Fas pathway in the metastatic process of osteosarcoma.
Koshkina NV; Khanna C; Mendoza A; Guan H; DeLauter L; Kleinerman ES
Mol Cancer Res; 2007 Oct; 5(10):991-9. PubMed ID: 17951400
[TBL] [Abstract][Full Text] [Related]
12. Effect of CD44 deficiency on in vitro and in vivo osteoclast formation.
de Vries TJ; Schoenmaker T; Beertsen W; van der Neut R; Everts V
J Cell Biochem; 2005 Apr; 94(5):954-66. PubMed ID: 15578568
[TBL] [Abstract][Full Text] [Related]
13. COPS3 amplification and clinical outcome in osteosarcoma.
Yan T; Wunder JS; Gokgoz N; Gill M; Eskandarian S; Parkes RK; Bull SB; Bell RS; Andrulis IL
Cancer; 2007 May; 109(9):1870-6. PubMed ID: 17366602
[TBL] [Abstract][Full Text] [Related]
14. Osteosarcomas in BALB/c female mice.
Frith CH; Johnson BP; Highman B
Lab Anim Sci; 1982 Feb; 32(1):60-3. PubMed ID: 6952039
[TBL] [Abstract][Full Text] [Related]
15. Deletion of Yin Yang 1 protein in osteosarcoma cells on cell invasion and CXCR4/angiogenesis and metastasis.
de Nigris F; Rossiello R; Schiano C; Arra C; Williams-Ignarro S; Barbieri A; Lanza A; Balestrieri A; Giuliano MT; Ignarro LJ; Napoli C
Cancer Res; 2008 Mar; 68(6):1797-808. PubMed ID: 18339860
[TBL] [Abstract][Full Text] [Related]
16. CD44 regulates arteriogenesis in mice and is differentially expressed in patients with poor and good collateralization.
van Royen N; Voskuil M; Hoefer I; Jost M; de Graaf S; Hedwig F; Andert JP; Wormhoudt TA; Hua J; Hartmann S; Bode C; Buschmann I; Schaper W; van der Neut R; Piek JJ; Pals ST
Circulation; 2004 Apr; 109(13):1647-52. PubMed ID: 15023889
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cell immunotherapy is effective for lung metastasis from murine osteosarcoma.
Joyama S; Naka N; Tsukamoto Y; Yoshikawa H; Itoh K
Clin Orthop Relat Res; 2006 Dec; 453():318-27. PubMed ID: 16906102
[No Abstract] [Full Text] [Related]
18. Loss of functional Fas ligand enhances intestinal tumorigenesis in the Min mouse model.
Fingleton B; Carter KJ; Matrisian LM
Cancer Res; 2007 May; 67(10):4800-6. PubMed ID: 17510409
[TBL] [Abstract][Full Text] [Related]
19. A novel mouse model of human breast cancer stem-like cells with high CD44+CD24-/lower phenotype metastasis to human bone.
Ling LJ; Wang S; Liu XA; Shen EC; Ding Q; Lu C; Xu J; Cao QH; Zhu HQ; Wang F
Chin Med J (Engl); 2008 Oct; 121(20):1980-6. PubMed ID: 19080260
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of malignant activities of nasopharyngeal carcinoma cells with high expression of CD44 by siRNA.
Shi Y; Tian Y; Zhou YQ; Ju JY; Qu L; Chen SL; Xiang ZG; Liu Y; Zhu LP
Oncol Rep; 2007 Aug; 18(2):397-403. PubMed ID: 17611662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
